Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Role of adenylyl cyclase 6 in the development of lithium-induced nephrogenic diabetes insipidus
Søren Brandt Poulsen, … , Timo Rieg, Robert A. Fenton
Søren Brandt Poulsen, … , Timo Rieg, Robert A. Fenton
Published April 6, 2017
Citation Information: JCI Insight. 2017;2(7):e91042. https://doi.org/10.1172/jci.insight.91042.
View: Text | PDF
Research Article Cell biology

Role of adenylyl cyclase 6 in the development of lithium-induced nephrogenic diabetes insipidus

  • Text
  • PDF
Abstract

Psychiatric patients treated with lithium (Li+) may develop nephrogenic diabetes insipidus (NDI). Although the etiology of Li+-induced NDI (Li-NDI) is poorly understood, it occurs partially due to reduced aquaporin-2 (AQP2) expression in the kidney collecting ducts. A mechanism postulated for this is that Li+ inhibits adenylyl cyclase (AC) activity, leading to decreased cAMP, reduced AQP2 abundance, and less membrane targeting. We hypothesized that Li-NDI would not develop in mice lacking AC6. Whole-body AC6 knockout (AC6–/–) mice and potentially novel connecting tubule/principal cell–specific AC6 knockout (AC6loxloxCre) mice had approximately 50% lower urine osmolality and doubled water intake under baseline conditions compared with controls. Dietary Li+ administration increased water intake and reduced urine osmolality in control, AC6–/–, and AC6loxloxCre mice. Consistent with AC6–/– mice, medullary AQP2 and pS256-AQP2 abundances were lower in AC6loxloxCre mice compared with controls under standard conditions, and levels were further reduced after Li+ administration. AC6loxloxCre and control mice had a similar increase in the numbers of proliferating cell nuclear antigen–positive cells in response to Li+. However, AC6loxloxCre mice had a higher number of H+-ATPase B1 subunit–positive cells under standard conditions and after Li+ administration. Collectively, AC6 has a minor role in Li-NDI development but may be important for determining the intercalated cell–to–principal cell ratio.

Authors

Søren Brandt Poulsen, Tina Bøgelund Kristensen, Heddwen L. Brooks, Donald E. Kohan, Timo Rieg, Robert A. Fenton

×

Figure 4

Li+ induces lower urine osmolality and higher water intake in AC6loxloxCre and AC6loxlox mice compared with standard diet.

Options: View larger image (or click on image) Download as PowerPoint
Li+ induces lower urine osmolality and higher water intake in AC6loxloxC...
Following an initial baseline period on standard diet, mice with deletion of AC6 in AQP2-expressing cells (AC6loxloxCre mice) and AC6loxlox control mice were either fed a standard diet or a Li+-containing diet for 15 days (study endpoint). Presented are summary data for (A) body weight, (B) food intake, (C) water intake, (D) urine osmolality, (E) plasma osmolality, (F) hematocrit, and (G) plasma [Li+]. Data on water intake and urine osmolality are equivalent to data on day 15 presented in Figure 3 and Supplemental Figure 1. Values are mean ± SEM. Numbers in parentheses indicate sample sizes. All statistical comparisons were performed using 2-way ANOVA followed by Holm-Sidak post-hoc tests. *P < 0.05.

Copyright © 2025 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts